Charting the Coronavirus: Is a Second Wave Coming?
By
Kennen MacKay
Published May 7, 2020
|
8 min watch
CNBC’s Meg Tirrell talks to Kennen MacKay, Managing Director and Co-Head of Biotechnology Research at RBC Capital Markets, about the progress of the coronavirus in the U.S.
Kennen MacKay
Managing Director, Co-Head of RBC Biotechnology Research,
Dr. Kennen MacKay is a Managing Director at RBC and Co-Head of RBC Biotechnology Research. Kennen has over 10 years of biotechnology experience and previously covered the biotechnology sector at Credit Suisse and Citigroup. Prior to his career on Wall St., Kennen served as Director of the Michelson Prize and Grants under Los Angeles billionaire Dr. Gary Michelson, where he vetted biotechnologies for development in the non-profit setting. Kennen received his Ph.D. in Biochemistry and Molecular Biology from UCLA and his BA in Biochemistry from Colorado College, where he was a 4-yr Academic All-American on the swim team.
COVID-19CoronavirusKennen MacKay
